BVT Knock-Out MOS/ DE000VU8F2B9 /
31/05/2024 13:47:20 | Diferencia-0.020 | Bid31/05/2024 | Ask31/05/2024 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
0.340EUR | -5.56% | 0.340 Volumen de oferta: 30,000 |
0.370 Tamaño/ Volumen/ Formato de Ask: 30,000 |
Mosaic Company | 26.52 USD | 31/12/2078 | Call |
GlobeNewswire
14:05
Autonomix Medical, Inc. Reports Full Year 2024 Financial Results and Provides Corporate Update
GlobeNewswire
14:00
Haoxi Health Technology Limited Reports Unaudited Financial Results for The Six Months Ended Decembe...
GlobeNewswire
14:00
Generation Lab Introduces First Platform that Measures Aging & Treatment Efficacy to Help Extend the...
GlobeNewswire
14:00
Autolus Therapeutics presents longer-term follow-up and additional data analysis of Pivotal Phase 2 ...
GlobeNewswire
14:00
Lipella Pharmaceuticals Announces Completion of Site Initiation Visit for Phase 2a Trial of LP-310 i...
GlobeNewswire
14:00
Milestone® Pharmaceuticals to Participate in the Upcoming Jefferies Global Healthcare Conference
GlobeNewswire
14:00
Aptose Announces $4.43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
GlobeNewswire
14:00
PodcastOne (Nasdaq: PODC) Appoints Wall Street Veteran Jon Merriman to Its Board of Directors
GlobeNewswire
14:00
ABM Named Among Barron’s 100 Most Sustainable Companies for Second Consecutive Year
GlobeNewswire
14:00
Iterum Therapeutics Receives FDA Acceptance of Resubmission of NDA for Oral Sulopenem for the treatm...
GlobeNewswire
14:00
SOND INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sonder Holdings Inc. Investors...
GlobeNewswire
13:30
Adaptive Biotechnologies Announces Data Supporting the Clinical Benefits of MRD Assessment with clon...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página